Anti Cancer Medicines

Anti Cancer APIs & Targeted Treatments

What Are Anti Cancer APIs & Targeted Treatments?

Pharmint provides a comprehensive range of anti-cancer APIs, chemical intermediates, and targeted therapies for pharmaceutical formulation, scale-up, and research purposes. This includes TKIs, cytotoxic agents, and hormone modulators essential for oncology drug development.

We serve pharma manufacturers, CROs, CDMOs, and research labs with GMP-grade oncology compounds, supported by regulatory documentation and global supply compliance.

What Types of Oncology Molecules Are Offered?

Our portfolio includes:

• Small-molecule APIs such as Afatinib, Letrozole, and Imatinib
• Targeted therapies like Cabozantinib and Pomalidomide
• Advanced intermediates including Camptothecin‑2 and 4‑Bromomethyl‑Benzonitrile

These molecules are used in:

• Oncology FDF development
• Clinical research and BE studies
• API synthesis and formulation trials

Who Should Source From This Category?

This section is tailored for:

• Pharma procurement managers sourcing oncology actives in bulk
• Formulators developing hormonal oncology drugs and TKIs
• CDMOs/CMOs engaged in contract manufacturing of anti-cancer therapies
• Research organizations exploring oncology pathways

What Compliance & Documentation Support Is Provided?

Pharmint ensures:

• GMP/ISO-aligned sourcing partners
• COA, MSDS, and DMF availability on select APIs
• Support for regulatory submissions, dossiers, and audits
• Export-ready documentation: end-use declarations, permits

What Are the Lead Times, MOQ & Packaging Details?

• MOQ: 100 g (R&D) to multi-kilo scale (commercial)
• Packaging: HDPE triple-layered bottles with optional nitrogen blanketing
• Lead Times: 7–21 business days, based on stock and region
• Sample Requests: Available to verified B2B buyers

What Are the Featured Oncology Products?

Product	CAS Number	Category	Use
Afatinib	850140-72-6	TKI	EGFR+ cancers
Letrozole	112809-51-5	Aromatase Inhibitor	Breast cancer
Imatinib Mesylate	220127-57-1	Kinase Inhibitor	CML, GIST
Camptothecin-2	7689-03-4	Intermediate	Topoisomerase inhibitor
Capecitabine Tablet 500mg	154361-50-9	Prodrug	Colorectal cancer

How Is Product Quality Assured?

Each shipment includes:

• Batch-specific COA and impurity profile
• GMP or ISO certification
• Optional third-party lab analysis
• Controlled shipment handling for cytotoxics

Bulk Oncology FAQs

Can Pharmint support bulk oncology API procurement?

Yes, we provide oncology APIs and intermediates in bulk with COA and regulatory support.

Are GMP and compliance documents included?

All products come with COA, MSDS, and traceability documents. DMFs available for selected molecules.

Does Pharmint help with tech transfer or CRO collaboration?

Yes, we work with global CROs/CMOs to support R&D, scale-up, and formulation.

Can I request custom packaging or compliance documents?

Absolutely. Packaging and export documentation can be tailored to your regulatory region.

What oncology classes are covered in this category?

We supply TKIs, hormonal APIs, cytotoxic agents, and oncology intermediates for solid and hematologic cancers.